Skip to main content
Fig. 2 | BMC Cancer

Fig. 2

From: Immune-related protein signature in serum stratify relapsed mantle cell lymphoma patients based on risk

Fig. 2

Kaplan Meier estimator comparing how MIPI and MIPIris stratify patients according to outcome. a and b are MIPI risk distribution (LR ≤ 5.7; 5.7 < IR < 6.2; 6.2 ≤ HR) with respect to overall survival and progression free survival respectively; c and d are MIPIris risk distribution (LR ≤ 3.97; 3.97 < IR < 5.62; 5.62 ≤ HR) with respect to overall survival and progression free survival respectively. LR = low risk, IR = intermediate risk, HR = high risk

Back to article page
\